MOUNTAIN VIEW, CA — (Marketwired) — 01/29/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the International Aortic Summit (IAS) from February 11-13 at the Hyatt Regency in Palm Beach, AW. The Company will showcase its Magellan Robotic Catheters and will conduct Magellan Robotic System demonstrations at exhibit booth #11."As I have experienced in my own practice, the Magellan Robotic Syste
MOUNTAIN VIEW, CA — (Marketwired) — 01/27/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first clinical procedure with the Magellan Robotic System in Australia. Interventional radiologists Dr. Gerard Goh and Dr. Jim Koukounaras, assisted by Professor Ken Thomson, performed the procedure at The Alfred Hospital in Melbourne, Australia. The Magellan Robotic System was installed in January 2015 in collaboration with Medt
MOUNTAIN VIEW, CA — (Marketwired) — 01/22/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the world–s first intravascular robot-assisted retrieval of an Inferior Vena Cava (IVC) Filter. Dr. Alan Lumsden, Vascular Surgeon and Director of the Methodist DeBakey Heart & Vascular Center, performed the procedure at Houston Methodist Hospital in Houston, Texas using the Magellan Robotic System to remove a filter manufacture
MOUNTAIN VIEW, CA — (Marketwired) — 01/20/15 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 27th Annual International Symposium on Endovascular Therapy (ISET) January 31-February 4 at the Diplomat Hotel in Hollywood, FL. The Company will showcase the new Magellan 6Fr Robotic Catheter and will conduct Magellan Robotic System demonstrations at exhibit booth #305.During this year–s ISET meetin
MOUNTAIN VIEW, CA — (Marketwired) — 11/20/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robotic prostatic artery embolization (PAE) in the United States. Dr. Sandeep Bagla, interventional radiologist, performed the procedure at Inova Alexandria Hospital in Alexandria, Virginia using the Magellan Robotic System."This is a major step forward in delivering a less invasive procedure for the treatment of benig
MOUNTAIN VIEW, CA — (Marketwired) — 11/17/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the 41st Annual VEITHsymposium® November 18 – 22 at the New York Hilton-Midtown in New York City. The Company will be conducting product demonstrations of the new Magellan 6Fr Robotic Catheter and exhibiting the Magellan Robotic System to Vascular Surgeons and Interventionalists at its exhibit booth (
MOUNTAIN VIEW, CA — (Marketwired) — 11/06/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today reported recent business highlights and financial results for the third quarter of fiscal year 2014 ended September 30, 2014.The Company shipped four systems in the quarter: two Magellan Robotic Systems and two Sensei® Robotic Systems. Two of the systems were recognized as revenue and two of the systems were shipped as evaluation units for the purpose of co
MOUNTAIN VIEW, CA — (Marketwired) — 11/04/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it will release its financial and operating results for the third quarter ended September 30, 2014, after market close on Thursday, November 6, 2014.Hansen Medical, Inc., based in Mountain View, California, is a global leader in Intravascular Robotics, developing products and technology designed to enable the accurate positioning, manipulation and con
MOUNTAIN VIEW, CA — (Marketwired) — 11/03/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the Company–s Magellan 6Fr Robotic Catheter has received European Conformity (CE) Marking for use in the peripheral vasculature. Achieving this milestone allows the Company to market the Magellan 6Fr Robotic Catheter in Europe and other countries that require the CE Mark.The 6Fr Robotic Catheter–s new dual-bend technology enables independent robotic